Serum Concentrations of Eosinophil Cationic Protein and Eosinophils of Patients with Kimura's Disease  by Ohta, Nobuo et al.
Allergology Internatinal Vol 56, No1, 2007 www.jsaweb.jp 45
Serum Concentrations of Eosinophil
Cationic Protein and Eosinophils of
Patients with Kimura’s Disease
Nobuo Ohta1, Shinichi Okazaki1,2, Shigeru Fukase1, Naoko Akatsuka1,
Masaru Aoyagi1 and Mitsunori Yamakawa2
ABSTRACT
Background: To clarify the role of eosinophils in the pathogenesis of Kimura’s disease and the values of
measuring serum levels of eosinophil cationic protein (ECP) for monitoring disease activity might be very im-
portant, but there are few reports about this matter.
Methods: A total 14 serum and 7 tissue samples from patients with Kimura’s disease were studied. The con-
centrations of ECP and cytokines (interleukin-4 (IL-4), granulocyte-macrophage colony-stimulating factor (GM-
CSF), and interleukin 5 (IL-5)) in sera from patients with Kimura’s disease were measured by enzyme-linked
immunosorbent assay (ELISA). The density of eosinophils and the degree of activation of eosinophils in the tis-
sue were also studied immunohistochemically.
Results: The concentration of ECP in sera from patients with Kimura’s disease was significantly higher than
that in the control group (p < 0.05). At the time of the remission, a significant decrease of ECP was observed. In
interfollicular areas, most infiltrated eosinophils were positive for EG2 antibody (64.0―94.0%) and the mean
percentage of EG2-positive eosinophils was 75.7%. The concentrations of IL-4, GM-CSF, and IL-5 in sera from
patients with Kimura’s disease were within normal ranges or below the detectable level in all sera examined.
Conclusions: Our findings suggest that eosinophils play an important role in the pathogenesis of Kimura’s
disease and ECP may be used as an additional parameter of disease activity.
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INTRODUCTION
Kimura’s disease is a rare benign disorder character-
ized by nodules found on the head and neck, associ-
ated with peripheral blood eosinophilia.1 The nodules
are located intradermally or subcutaneously. His-
tologically, the lesions comprise cellular and endothe-
lial vascular elements. The lymphocytes present as
focal infiltration with primary and secondary lym-
phoids. Infiltration of lymphocytes and histiocytes
with a predominance of eosinophils is extensive.2,3
While the etiology is not well understood, the disease
is frequently associated with marked eosinophilia and
an elevated serum level of IgE. Eosinophils are
widely recognized as being proinflammatory cells and
are considered to damage the tissues by releasing
chemical mediators, such as eosinophil cationic pro-
tein (ECP). Recently, it has become possible to rec-
ognize eosinophil activation using the immunohisto-
chemical marker, EG-2. To investigate the role of
eosinophil in the pathogenesis of Kimura’s disease,
the concentrations of ECP in sera from patients with
Kimura’s disease were measured and the EG-2 posi-
tivity of eosinophils in the lesion was investigated im-
munohistochemically.
METHODS
SUBJECTS
Seven patients with Kimura’s disease were referred
to our department; six men and one woman aged
from 21 to 72 years (mean age 43). The clinical de-
tails of these patients are shown in Table 1. The main
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Fig. 1 Serum levels of ECP of patients with Kimura’s dis
ease and control subjects. The concentration of ECP in sera 
from patients with Kimura’s disease was significantly higher 
than that of control.
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Fig. 2 The serum concentrations of ECP and the number 
of eosinophils. The serum ECP levels were　not signifi
cantly corelated with the number of eosinophils from pa
tients with Kimura’s disease. (p＝0.094)
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Table 1 Clinical Features of patients with Kimura’ sdisease
EG-2 positive
eosinophils
 Blood
Eosinophil countsDurationLocationAgeSexCase
71.4%1650 (19%) 5 yrsParotid31F1
79.8%1840 (23%) 5 yrsParotid29M2
72.4%1830 (30%)10 yrsParotid72M3
80.8%1512 (27%) 1 yrsNeck28M4
67.7%1250 (15%) 4 yrsParotid58M5
94.0%4800 (36%)20 yrsParotid62M6
64.0% 830 (10%) 5 yrsParotid21M7
parotid: parotid gland
findings were irregular subcutaneous nodules (25―70
mm in diameter) that were itchy, sometimes fluctu-
ated in size, and were tender. There was some discol-
oration of the overlying skin. The control group con-
sisted of 5 (3 men and 2 women) healthy, non-allergic
volunteers aged from 21 to 32 years (mean age 23.5).
IMMUNOHISTOCHEMICAL STUDY
Tumors and involved lymph nodes obtained from bi-
opsy or surgically removed materials were fixed in
10% formalin for 1 or 2 days and dehydrated with a se-
ries of ethanol solutions, and then embedded in
paraffin-wax. Sections of 3 mm in thickness were de-
waxed in xylene and dehydrated. The sections were
washed with 0.01 M phosphate-buffered saline (PBS)
(pH 7.2) containing 0.15 M NaCl2 and 0.01% Triton X-
100 and incubated for 2 hours with the murine mono-
clonal anti-human ECP antibody, EG-1 or EG-2
(mouse IgG1, Pharmacia, Uppsala Sweden), which
was diluted 1 : 10 in PBS containing 0.1% bovine se-
rum albumin. Controls for nonspecific staining were
incubated with 10 mgml of mouse IgG1 (DAKO,
Glostrup, Denmark). Sections were washed and incu-
bated with biotinylated rabbit antibody to mouse IgG,
IgA, and IgM (Immunotech, Tokyo, Japan) for 1hour.
The sections were incubated with the ABC reagent
(Vectastain, ABC Elite; Vector Laboratories, Burl-
ingame, CA), followed by 3, 3-diaminobenzidine (Do-
jin Chemicals, Kumamoto, Japan) as the chromogen.
Finally, the slides were counterstained with hematox-
ylin.
METHODS OF ASSESSMENT OF SLIDES
Eosinophils containing no or only one EG-2 positive
particle in cytoplasm were assessed as EG-2 negative
cells. EG-2 positive eosinophils per total cells in a mi-
croscopical field (X400; as area = 0.0384 mm2) were
counted in the interfollicular area in each specimen.
More than five areas were evaluated using an eye-
piece graticule.
QUANTITATION OF ECP, GM-CSF, IL-4, AND IL-5
The measurement of serum ECP levels was per-
formed using a Pharmacia ECP kit (Uppsala, Swe-
den), according to the manufacturer’s directions for
use. GM-CSF, IL-4, and IL-5 were also measured us-
ing a commercial enzyme-linked immunosorbent as-
ECP and Kimura’s Disease
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Fig. 3 The serum concentrations of ECP/the number of 
eosinophils. The serum ECP/eosinophil ratio was signifi
cantly high in patients with Kimura’s disease compared with 
control. (p＜0.05)
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Fig. 4 The serum concentrations of ECP in 3 patients with 
Kimura’s disease (patient #2, #5 and #6) in the active stage 
and the remission stage. The serum ECP levels were ele
vated in the active stage of Kimura’s disease and were sig
nificantly decreased in the remission stage.
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say (ELISA) kit (human GM-CSF assay kit; Genzyme,
Denmark, IL-4 assay kit; R&D Systems, Inc., USA,
human IL-5 assay kit; R&D Systems, Inc., USA).
STATISTICAL EVALUATION
Wilcoxon’s signed-rank test, Mann-Whitney U test
and linear correlation analysis were used.
RESULTS
CONCENTRATION OF ECP
Figure 1 shows the serum ECP values. The concen-
tration of ECP in sera from patients with Kimura’s
disease was significantly higher than that in the con-
trol group (p < 0.05). Figure 2 shows that the serum
ECP level was not significantly correlated with the
number of eosinophils. Figure 3 shows that the ratio
of serum concentration of ECPthe number of
eosinophils was significantly higher than those of
control. Figure 4 shows the serum concentration of
ECP in 3 patients in the presence of eosinophilia and
after the disappearance of eosinophilia.
IMMUNOHISTOCHEMICAL FINDINGS
In interfollicular areas, most infiltrated eosinophils
were positive for EG2 antibody and the mean percent-
age of EG2-positive eosinophils was 75.7% (64.0―
94.0%) (Table 1). In 2 cases of high levels of the ECP
concentration, lymph node structure was well-
preserved; marked follicular hyperplasia with large
germinal centers and infiltration of eosinophils in in-
terfollicular areas and marginal sinuses were ob-
served, and infiltrated eosinophils were almost EG-2
positive (Figs. 5―7).
CONCENTRATION OF GM-CSF, IL-4, AND IL-5
The concentrations of GM-CSF were below the de-
tectable levels in all sera examined. IL-4 and IL-5
were detectable in the sera from one out of 13 sera
from 8 patients and these levels were within normal
ranges.
DISCUSSION
Kimura’s disease is an eosinophilic inflammatory dis-
order characterized by marked eosinophilia, an ele-
vated titer of serum IgE, and recurrent subcutaneous
inflammatory nodules. These subcutaneous lesions,
often affecting the lymph nodes, characteristically
display fibroinflammatory pseudotumors consisting
of follicular lymphoid hyperplasia with prominent ger-
minal centers, as well as interstitial fibroplasia with
marked eosinophilic infiltration. It has been stated
that Kimura’s disease may be associated with allergy,
endocrinic disorders, autoimmune diseases, para-
sites, viral infections and inflammation, although its
etiology is not well-understood. Recent studies sug-
gest, based on findings such as elevated serum IgE,
an increased number of eosinophils in peripheral
blood and in lesions, and an increased number of
mast cells, that eosinophils may mainly be responsi-
ble for Kimura’s disease.1-5
Recently, the role of the eosinophils in allergic dis-
eases has been suggested by a number of studies.6
Eosinophils contain several highly cytotoxic proteins,
such as ECP, eosinophil peroxidase, eosinophil pro-
tein X, and major basic protein. ECP has been dem-
onstrated to cause damage to airway epithelium re-
sembling the histopathologic findings in asthma,7,8
and in vitro study has shown that ECP acts upon
mast cells and releases histamine.8-11 To clarify the
role of eosinophils in the pathogenesis of Kimura’s
disease, the concentrations of ECP in sera from pa-
tients with Kimura’s disease were measured and the
EG-2 positivity of eosinophils in the lesion was inves-
tigated immunohistochemically. Serum ECP levels
were elevated in the active stage of Kimura’s disease
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Fig. 5 A biopsy specimen from a right parotid of patient #4 
showed characteristic proliferative lymph folicles with prolif
eration of blood vessels and infiltration of plasma cels and 
increased eosinophils partialy forming eosinophilic abs
cesses. (HE, original magnification ×100)
Fig. 6 A biopsy specimen from the right parotid of patient 
#4 showed the interfolicular area occupied with densely 
packed EG-1 positive eosinophils. (LF: secondary lymphoid 
folicle, counterstained with hematoxylin, original magnifica-
tion ×250)
Fig. 7 A biopsy specimen from the right parotid of patient 
#4 showed the interfolicular area occupied with densely 
packed EG-2 positive eosinophils. (LF: secondary lymphoid 
folicle, counterstained with hematoxylin, original magnifica-
tion ×250)
compared with those of healthy controls. As shown in
Figures 2―4, the ECP levels were not significantly
correlated with the number of eosinophils, and the ra-
tio of ECPeosinophils in patients with Kimura’s dis-
ease was significantly higher than those of control.
These findings suggested that ECP was not merely
reflected with the number of the eosinophils, and
surely released from activated eosinophils. Although
ECP is probably important for the pathogenesis of
Kimura’s disease, there have been few case reports
on the subject.12 This is the first report to demon-
strate the elevation of ECP in the sera from patients
with Kimura’s disease.
In the interfollicular areas, most infiltrated eosino-
phils were positive for EG-2 antibody; the mean per-
centage of EG2-positive eosinophils was 75.7%. These
findings indicated that the infiltrated eosinophils of
patients with Kimura’s disease were activated. We
speculated that the increase in the number of eosino-
phils may be caused by an increase in the production
of eosinophils, the prolongation of their life span, or
an increase in chemotaxis. Among the various hema-
topoietic factors, IL-4, IL-5, and GM-CSF stimulate
eosinophil production and activate these cells.4,5 To
investigate the role of these cytokines in inductive
eosinophilopoiesis and the activation of eosinophils in
Kimura’s disease, the serum concentration of IL-4, IL-
5, and GM-CSF were measured. Contrary to our ex-
pectations, the serum concentrations of these cytoki-
nes were not elevated compared with those of healthy
controls. The number of IL-4, IL-5, eotaxin and
RANTES-expressing mast cells and T cells were in-
creased in the lesions,13 and IL-5 was produced from
the site of a granuloma and lymph nodes of patients
with Kimura’s disease after stimulation with candida
antigen.4 Although the serum levels of GM-CSF and
TNF were elevated and correlated with disease activ-
ity in a patient with Kimura’s disease,14 serum con-
centrations of IL-5, GM-CSF, and IL-3 were not de-
tected in almost half of patients with various eosino-
philia including Kimura’s disease.15 In asthma pa-
tients, a significant positive correlation was found be-
tween serum levels of ECP and IL-5, however, serum
IL-5 levels were not high enough to evaluate the dis-
ease activity.16 Sensitivity is the most concerning
problem in the measurement system of IL-5. Al-
though IL-5 is one of the factors that activate eosino-
phils in both local sites and peripheral blood, the
measurement of serum IL-5 is not useful for monitor-
ing Kimura’s disease.
Based on these findings, we speculated that the in-
ECP and Kimura’s Disease
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filtrated eosinophils of patients with Kimura’s disease
were activated and ECP may be used as an additional
parameter of disease activity.
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